Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Medical Sciences|March 9, 2026
Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancerCheng-Che Wu, Ping-Fu Yang, Shu-Jyuan Chang, et al.Breast Cancer (Dove Medical Press)|April 8, 2026
Prognostic Value of Ki-67 and Progesterone Receptor for Risk Stratification and Outcomes by Adjuvant Chemotherapy in Early Luminal-Type Breast CancerHung-Hsun Chen, Shu-Jyuan Chang, Jung-Yu Kan, et al.Cancers|November 13, 2021
Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 94Mei-Ren Pan, Cheng-Che Wu, Jung-Yu Kan, et al.Cancers|January 8, 2020
Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast CancerMei-Ren Pan, Cheng-Che Wu, Jung-Yu Kan, et al.International Journal of Molecular Sciences|September 23, 2022
Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast CancerChung-Liang Li, Sin-Hua Moi, Huei-Shan Lin, et al.American Journal of Cancer Research|February 10, 2022
De-glycosylated membrane PD-L1 in tumor tissues as a biomarker for responsiveness to atezolizumab (Tecentriq) in advanced breast cancer patientsFu Ou-Yang, Chung-Liang Li, Chia-Chi Chen, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 8, 2026
Intraoperative radiation therapy (IORT) in Taiwanese breast cancer patients: factors influencing local relapse risk and disease-free survivalShen-Liang Shih, Jung-Yu Kan, Hidenobu Takahashi, et al.Experimental & Molecular Medicine|October 28, 2021
Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancerMing-Feng Hou, Fu Ou-Yang, Chung-Liang Li, et al.Cancer Genomics & Proteomics|January 2, 2026
Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast CancerFang-Ming Chen, Chung-Liang Li, Mei-Ren Pan, et al.Journal of Breast Cancer|July 6, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer ManagementJiun-I Lai, Chih-Chiang Hung, Chin-Yao Lin, et al.Pageof 2